Dermatology · Searcy, AR
NPI
1205829298
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1903 E Beebe Capps Blvd
Searcy, AR, 72143
Phone (501) 279-3838
Groups this clinician bills Medicare through
Medicare paid, 2024
$314K
10,183 services
Medicare patients, 2024
1,627
Average age 76
Drug cost, 2024
$566K
2,522 prescriptions
Company payments, 2025
$19.58
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bradley A White was code 17003 (destruction skin lesion), 4,774 times for 729 patients. In total Bradley A White billed 10,183 services in 59 codes, and Medicare paid $314K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 4,774 | 729 | $4.25 | $20K |
| 17000 Destruction Skin Lesion | Office | 1,403 | 959 | $35.08 | $49K |
| 99213 Office E&M - Established | Office | 1,300 | 1,036 | $54.20 | $70K |
| 88305 Surgical Pathology Examination | Office | 657 | 410 | $24.72 | $16K |
| 99214 Office E&M - Established | Office | 421 | 359 | $77.69 | $33K |
| 99212 Office E&M - Established | Office | 243 | 223 | $28.45 | $6,914 |
| 17110 Destruction Skin Lesion | Office | 201 | 189 | $65.35 | $13K |
| 99203 Office E&M - New | Office | 160 | 160 | $64.52 | $10K |
| 17281 Destruction Skin Lesion | Office | 126 | 106 | $110.43 | $14K |
| 17004 Destruction Skin Lesion | Office | 118 | 72 | $107.04 | $13K |
| 17261 Destruction Skin Lesion | Office | 106 | 83 | $86.38 | $9,156 |
| 99204 Office E&M - New | Office | 89 | 89 | $99.10 | $8,820 |
| 17271 Destruction Skin Lesion | Office | 82 | 68 | $92.14 | $7,556 |
| 11102 Skin Biopsy | Office | 72 | 72 | $58.97 | $4,246 |
| 17280 Destruction Skin Lesion | Office | 56 | 51 | $77.46 | $4,338 |
By year: 2022 $364K for 12,070 services; 2023 $309K for 10,396 services; 2024 $314K for 10,183 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 657 | 410 | $24.72 | $16K |
Medicare prescription drug claims, 2024
In 2024, the drug Bradley A White prescribed most often to Medicare patients was Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc), with 506 prescriptions and refills. In total Bradley A White wrote 2,522 Medicare prescriptions that cost $566K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 506 | 521 | 224 | $9,345 |
| Triamcinolone Acetonide Generic | 294 | 318 | 128 | $1,820 |
| Clobetasol Propionate Generic | 218 | 226 | 96 | $8,816 |
| Fluticasone Propionate Generic | 150 | 150 | 78 | $1,954 |
| Minocycline Hcl Generic | 145 | 159 | 40 | $5,106 |
| Prednisone Generic | 131 | 131 | 98 | $433 |
| Minoxidil Generic | 124 | 157 | 27 | $1,021 |
| Cephalexin Generic | 122 | 141 | 66 | $2,261 |
| Hydrocortisone Generic | 113 | 117 | 66 | $578 |
| Doxepin Hcl Generic | 73 | 89 | 22 | $1,649 |
| Terbinafine Hcl Generic | 62 | 134 | 52 | $1,033 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 53 | 59 | 19 | $782 |
| Doxycycline Hyclate Generic | 49 | 49 | Under 11 | $1,248 |
| Acyclovir Generic | 49 | 61 | 17 | $299 |
| Halobetasol Propionate Generic | 42 | 44 | 15 | $3,275 |
Brand drugs: 72 claims; generic drugs: 2,450 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bradley A White $19.58 ($19.58 in general payments such as food, travel and fees) from 1 company. The largest payer was Galderma Laboratories, L.P. with $19.58.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 1 | $19.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.